Grove Bank & Trust’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21K Hold
95
– – ﹤0.01% 559
2026
Q2
$18.5K Sell
95
-1
-1% -$207 ﹤0.01% 575
2026
Q1
$21.6K Buy
96
+1
+1% +$249 ﹤0.01% 532
2025
Q4
$22.9K Hold
95
– – ﹤0.01% 525
2025
Q3
$26K Hold
95
– – ﹤0.01% 506
2025
Q2
$24.5K Buy
95
+11
+13% +$2.62K ﹤0.01% 507
2025
Q1
$18.8K Buy
84
+54
+180% +$12.6K ﹤0.01% 526
2024
Q4
$6.86K Buy
30
+16
+114% +$3.85K ﹤0.01% 567
2024
Q3
$3.42K Buy
+14
New +$3.13K ﹤0.01% 593
2024
Q1
– Sell
-49
Closed -$8.43K – 596
2023
Q4
$8.43K Hold
49
– – ﹤0.01% 504
2023
Q3
$7.25K Buy
49
+33
+206% +$5.97K ﹤0.01% 548
2023
Q2
$3.5K Hold
16
– – ﹤0.01% 577
2023
Q1
$3.5K Buy
+16
New +$3.47K ﹤0.01% 597

Other funds holding RMD

Grove Bank & Trust's RMD Position: Q3 2026 in Review

Grove Bank & Trust held its ResMed (RMD) position steady in Q3 2026 at 95 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Grove Bank & Trust first reported a position in RMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $26K in Q3 2025. 22 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Grove Bank & Trust held 95 shares of ResMed worth $21K as of Q3 2026.
  • Grove Bank & Trust left its ResMed share count unchanged in Q3 2026.
  • ResMed made up ﹤0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #559 holding.
  • Grove Bank & Trust first reported a position in ResMed in Q1 2023 and has held it in 13 quarters since.
  • Grove Bank & Trust's ResMed position peaked at $26K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.